Searchable abstracts of presentations at key conferences in endocrinology

ea0070aep546 | General Endocrinology | ECE2020

Late effects of allogeneic stem cell transplants on the endocrine and metabolic systems

Ng Nicholas , Moloney David , Healy Marie-Louise

Stem cell transplants are used to treat and cure many types of haematological malignancies as well as rare solid-organ tumours. The conditioning regimes, medications and potential graft vs host disease can have effects on many organ systems in the body. The Endocrinology Department has designed a follow-up service over the past 3 years for patients in remission due to increasing awareness of the potential endocrinological and metabolic effects of allogenic stem cell transplant...

ea0104p65 | Diabetes & Metabolism | SFEIES24

Case: the glycaemic effect of GLP-1 receptor agonist semaglutide as an adjuvant therapy in HNF1-α MODY

Lonergan Eibhlin , Ng Nicholas , Slattery David

MODY as a result of a genetic variant in the HNF1-α gene is traditionally treated with sulphonylureas, often with eventual progression to insulin use due to the loss of beta cell function. We present the case of a 58-year-old female who attended the diabetes service for many years for a genetically confirmed diagnosis of HNF1-α MODY. She was originally diagnosed with pre-diabetes at the age of 16 and eventually commenced on oral hypoglycaemic agents (OHAs) at the age...

ea0056p367 | Diabetes (to include epidemiology, pathophysiology) | ECE2018

Diagnosis and optimal medical management of patients with maternally inherited diabetes and deafness (MIDD)

Ng Nicholas , Sanchez Begonia , McCarrick CJ , Mangan Cian , Byrne Maria

Background: Maternally inherited diabetes and deafness (MIDD) is a rare disease affecting approximately 1% of all diabetics. The most common mutation involved is a single base mutation (A-G) at position 3243 within the tRNALEU(UUR) gene. The clinical characteristics normally associated with this disease include sensorineural hearing loss, macular pattern dystrophy, cardiomyopathy, and diabetes. This study aims to identify clinical phenotype and insulin secretory res...

ea0104p144 | Neuroendocrinology | SFEIES24

Case: recurrent vaginal paraganglioma with hypertension in pregnancy

Lonergan Eibhlin , Ng Nicholas , O'Shea Donal , Crowley Rachel K.

Paraganglioma is a rare neuroendocrine tumour. There are few case reports in the literature describing vaginal paraganglioma to date. We present the case of a 37-year-old female referred to endocrinology services with symptomatic hypertension, initially noted during her first pregnancy three years prior. This was on a background of a vaginal paraganglioma diagnosed in 2006 which was excised by gynaecology services without complication. Her first pregnancy in 2021 was notable f...

ea0056p378 | Diabetes (to include epidemiology, pathophysiology) | ECE2018

Description of clinical, biochemical and radiological variability of Hepatocyte Nuclear Factor-1βeta (HNF1β) Mutations

Zamuner Matilde Bettina Mijares , Ng Nicholas Khay Jin , Siddique Nadia , Burke Marie , Byrne Maria

Background: HNF1β mutations are one of the commonly identified genetic causes of renal malformations, but one of the less common forms of MODY. HNF1β is involved in the development of kidneys, liver, pancreas, intestine and urogenital tract. Patients can present with distinctive but highly variable clinical features. The aim of this study is to evaluate the clinical, biochemical and radiological variability of HNF1β variants and the challenge of management on th...